Annual Short Term Debt
$5.33 M
+$2.54 M+90.67%
December 31, 2023
Summary
- As of February 24, 2025, MRSN annual short term debt is $5.33 million, with the most recent change of +$2.54 million (+90.67%) on December 31, 2023.
- During the last 3 years, MRSN annual short term debt has risen by +$3.90 million (+271.26%).
- MRSN annual short term debt is now at all-time high.
Performance
MRSN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$15.21 M
+$3.22 M+26.90%
September 30, 2024
Summary
- As of February 24, 2025, MRSN quarterly short term debt is $15.21 million, with the most recent change of +$3.22 million (+26.90%) on September 30, 2024.
- Over the past year, MRSN quarterly short term debt has stayed the same.
- MRSN quarterly short term debt is now at all-time high.
Performance
MRSN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
MRSN Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.7% | 0.0% |
| 3 y3 years | +271.3% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
MRSN Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.7% | at high | +560.5% |
| 5 y | 5-year | at high | +271.3% | at high | +1088.4% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Mersana Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.21 M(+26.9%) |
| Jun 2024 | - | $11.99 M(+36.9%) |
| Mar 2024 | - | $8.76 M(+64.1%) |
| Dec 2023 | $5.33 M(+90.7%) | $5.33 M(+70.1%) |
| Sep 2023 | - | $3.14 M(+3.7%) |
| Jun 2023 | - | $3.02 M(+4.2%) |
| Mar 2023 | - | $2.90 M(+3.8%) |
| Dec 2022 | $2.80 M(+21.5%) | $2.80 M(+3.7%) |
| Sep 2022 | - | $2.70 M(+4.1%) |
| Jun 2022 | - | $2.59 M(+7.8%) |
| Mar 2022 | - | $2.40 M(+4.4%) |
| Dec 2021 | $2.30 M | $2.30 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $2.24 M(-4.6%) |
| Jun 2021 | - | $2.35 M(+49.4%) |
| Mar 2021 | - | $1.57 M(+9.3%) |
| Dec 2020 | $1.44 M(-50.2%) | $1.44 M(+12.3%) |
| Sep 2020 | - | $1.28 M(-54.2%) |
| Jun 2020 | - | $2.79 M(+20.6%) |
| Mar 2020 | - | $2.32 M(-19.7%) |
| Dec 2019 | $2.89 M(>+9900.0%) | $2.89 M(+24.8%) |
| Sep 2019 | - | $2.31 M(+11.5%) |
| Jun 2019 | - | $2.07 M(+3.4%) |
| Mar 2019 | - | $2.00 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Mersana Therapeutics annual short term debt?
- What is the all time high annual short term debt for Mersana Therapeutics?
- What is Mersana Therapeutics annual short term debt year-on-year change?
- What is Mersana Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly short term debt year-on-year change?
What is Mersana Therapeutics annual short term debt?
The current annual short term debt of MRSN is $5.33 M
What is the all time high annual short term debt for Mersana Therapeutics?
Mersana Therapeutics all-time high annual short term debt is $5.33 M
What is Mersana Therapeutics annual short term debt year-on-year change?
Over the past year, MRSN annual short term debt has changed by +$2.54 M (+90.67%)
What is Mersana Therapeutics quarterly short term debt?
The current quarterly short term debt of MRSN is $15.21 M
What is the all time high quarterly short term debt for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly short term debt is $15.21 M
What is Mersana Therapeutics quarterly short term debt year-on-year change?
Over the past year, MRSN quarterly short term debt has changed by $0.00 (0.00%)